British court rules drug data must be shared

The Court of Appeal in London has ruled the National Institute for Health and Clinical Excellence must reveal how it calculated that certain Alzheimer's drugs weren't cost-effective for some patients. The court said the institute had acted unfairly by not fully disclosing how it evaluated the drugs, and the move highlights a rising tension between cash-strapped entities that pay for healthcare against patients and drug companies.